To use all functions of this page, please activate cookies in your browser.
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Sézary's disease
Sézary's disease (or "Sézary syndrome") is a type of cutaneous lymphoma characterized by Albert Sézary.[1] "Sézary's cells" are T-cells that have pathological quantities of mucopolysaccharides. Sézary's disease is sometimes considered a late stage of mycosis fungoides. Additional recommended knowledge
GeneralSezary syndrome and Mycosis Fungoides are T-cell lymphomas whose primary manifestation is in the skin. EtiologyHTLV has thought to have been associated with both of the above cutaneous mycoses. SymptomsThe hallmark symptoms for Sezary Syndrome are (1) Generalized erythroderma (2)Lymphadenopathy, and (3) Atypical T-cells ("Sezary cells") in the peripheral blood. TreatmentVorinostat (Zolinza®) is a second-line drug for CTCL. Treatments are often used in combination. References
Categories: Hematology | Types of cancer |
|||||||||||
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Sézary's_disease". A list of authors is available in Wikipedia. |
- Amorfix announces leading sensitivity for prion detection in spiked human blood samples
- KDR Biotech markets DASGIP Parallel Bioreactor Systems in Korea
- Virulence factor of the influenza A virus mapped in real-time
- More sensitive MRI diagnostics thanks to innovative “elastic” contrast media
- Emerging gene editing approach seeks broad spectrum crop disease resistance